Isomorphic Labs

Isomorphic Labs Limited

AI LabBig Tech

IsoIsomorphic

British multinational AI biotech company from London (DeepMind spin-off, Alphabet Inc. subsidiary). Founded 2021 by Sir Demis Hassabis (2024 Nobel laureate for AlphaFold). Builds a Drug Design Engine on AlphaFold 3 foundations. Series A $600M @ Thrive Capital, partnerships: Novartis, Eli Lilly, Johnson & Johnson.

Country of originUnited Kingdom

HQLondonUnited Kingdom

www.isomorphiclabs.com LinkedIn Wikipedia

01 · About

Isomorphic Labs

London, United Kingdom

Founders

Sir Demis Hassabis
Founder & CEO. Concurrent CEO of DeepMind (parent spin-off origin). 2024 Nobel Prize in Chemistry laureate for AlphaFold (jointly with John Jumper and David Baker). Knight of the United Kingdom (2024).

02 · What they do

Domain of activity

3 areas · 5 technologies · 3 industries

What they do3Areas

Language models
Multimodal models
Simulation & training environments

How they do it5Technologies

Foundation Models
Generative AI
Multimodal AI
Fine-tuning
Reinforcement Learning

Who for3Industries

Pharma & biotech
Healthcare
Research & science

03 · Geography

Global presence

HQ London · 2 offices · 3 regions

EuropeEuropean UnionGlobal

04 · Metrics

Scale & funding

growthdevelopment stage

Privatenot listed

operationalstatus

07 · Classification

Profile & metadata

4 classification · 4 external links

Classification

Statusoperational
Development stagegrowth
Listed onNoprivate
Organization typeAI Lab+ Big Tech

External links

08 · Related content

Articles

2 articles

News25 August 2026

When AI designs a drug, who counts as the inventor?

US patent law requires a human inventor even when an AI actually designed the drug. MIT Technology Review shows how biotech firms work around the gap and why lawyers say the rules must change.

News16 July 2026

Ex-OpenAI researcher raises $200M for AI drug discovery at $2B valuation

Miles Wang, an OpenAI researcher focused on AI-accelerated biological discovery, is leaving to launch a drug discovery startup at a $2B valuation. On the same day, Chai Discovery announced a $400M round at a $3.8B valuation.